A Bayesian path analysis to estimate causal effects of bazedoxifene acetate on incidence of vertebral fractures, either directly or through non-linear changes in bone mass density

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Statistical Methods in Medical Research

• Publication date

  2016-02-01

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1177/0962280212456655PMID 22967963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacogenetics of osteoporosis.

  2014cited by this paper
• Architecture of the superintegron in Vibrio cholerae: identification of core and unique genes

  2013cited by this paper
• A review of causal estimation of effects in mediation analyses

  2012cited by this paper
• Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS)

  2011cited by this paper
• Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis

  2011cited by this paper
• Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥ 50 y: a population-based cohort study.

  2011cited by this paper
• Prediction of Vertebral Fractures Is Specific for Gender and Site of Bone Mineral Density Measurement

  2010cited by this paper
• Peak bone mass from longitudinal data: Implications for the prevalence, pathophysiology, and diagnosis of osteoporosis

  2010cited by this paper
• Genetics of osteoporosis: perspectives for personalized medicine.

  2010cited by this paper
• Pharmacogenetics of osteoporosis

  2010cited by this paper
• Identification, Inference and Sensitivity Analysis for Causal Mediation Effects

  2010cited by this paper
• Role of Trabecular Microarchitecture and Its Heterogeneity Parameters in the Mechanical Behavior of Ex Vivo Human L3 Vertebrae

  2010cited by this paper
• Conceptual issues concerning mediation, interventions and composition

  2009cited by this paper
• Prevalence and risk factors of radiographic vertebral fracture in postmenopausal Vietnamese women.

  2009cited by this paper
• Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial

  2009cited by this paper
• High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women

  2009cited by this paper
• "Proportion explained": a causal interpretation for standard measures of indirect effect?

  2009cited by this paper
• The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS)

  2009cited by this paper
• Bone mineral density changes during the menopause transition in a multiethnic cohort of women.

  2008cited by this paper
• Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3‐Year, Randomized, Placebo‐, and Active‐Controlled Clinical Trial

  2008cited by this paper
• Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women

  2008cited by this paper
• Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

  2007cited by this paper
• Causal Mediation Analyses with Rank Preserving Models

  2007cited by this paper
• Mild prevalent and incident vertebral fractures are risk factors for new fractures

  2007cited by this paper
• Effects of Bazedoxifene on BMD and Bone Turnover in Postmenopausal Women: 2‐Yr Results of a Randomized, Double‐Blind, Placebo‐, and Active‐Controlled Study

  2007cited by this paper
• Quantifying the indirect treatment effect via surrogate markers

  2006cited by this paper
• An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

  2006cited by this paper
• Estimation of Direct Causal Effects

  2006cited by this paper
• Bmc Medical Research Methodology Open Access Motor Function in Parkinson's Disease and Supranuclear Palsy: Simultaneous Factor Analysis of a Clinical Scale in Several Populations

  2006cited by this paper
• The Mediation Proportion: A Structural Equation Approach for Estimating the Proportion of Exposure Effect on Outcome Explained by an Intermediate Variable

  2005cited by this paper
• Uses and limitations of bone mineral density measurements in the management of osteoporosis.

  2005cited by this paper
• Assessment of fracture risk: who should be treated for osteoporosis?

  2005cited by this paper
• A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects.

  2004cited by this paper
• Bone loss and bone size after menopause.

  2003cited by this paper
• Bone loss and bone size after menopause.

  2003cited by this paper
• Discriminatory Ability of Quantitative Ultrasound Parameters and Bone Mineral Density in a Population‐Based Sample of Postmenopausal Women With Vertebral Fractures: Results of the Basel Osteoporosis Study

  2002cited by this paper
• Architectural changes independent of bone mineral in osteoporosis.

  2002cited by this paper
• Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.

  2002cited by this paper
• Incidence of Vertebral Fracture in Europe: Results From the European Prospective Osteoporosis Study (EPOS)

  2002cited by this paper
• A method to assess the proportion of treatment effect explained by a surrogate endpoint

  2001cited by this paper
• WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility

  2000cited by this paper
• The validation of surrogate endpoints in meta-analyses of randomized experiments.

  2000cited by this paper
• Osteoporosis. Frequency, consequences, and risk factors.

  1996cited by this paper
• Statistical validation of intermediate endpoints for chronic diseases.

  1992cited by this paper

• LongITools: Dynamic longitudinal exposome trajectories in cardiovascular and metabolic noncommunicable diseases

  2021cites this paper
• Statistical methods for building better biomarkers of chronic kidney disease

  2019cites this paper
• Accounting for mediation in cyclist-vehicle crash models: A Bayesian mediation analysis approach.

  2019cites this paper
• Effects of Bazedoxifene on Bone Mineral Density and Fracture in Post-Menopausal Osteoporotic Women: a Systematic Review and Meta-Analysis

  2018cites this paper
• Causality on longitudinal data: Stable specification search in constrained structural equation modeling

  2015cites this paper
• Hip Fracture in the Elderly: A Re-Analysis of the EPIDOS Study with Causal Bayesian Networks

  2015cites this paper
• Monitoring of osteoporosis therapy.

  2014cites this paper
• Analysis of risk factors of hip fracture with causal Bayesian networks

  2014cites this paper